Unlocking Value in IP Investments

Latest News

No items found.
Firm Overview

SIM IP is focused on intellectual property based financing, investment and monetization opportunities. SIM IP invests across IP as an asset class and across jurisdictions, primarily focusing on the US, Europe and Asia.

Our Expertise
  • We are experts in sourcing, evaluating, managing and financing IP-based transactions.

  • We identify overlooked value in a company’s IP.

  • We structure transactions to accommodate the unique needs of IP owners.

  • We invest with conviction based on our decades of experience.

Investment Strategies

SIM IP provides unparalleled access to global IP opportunities.

01

IP Licensing

Licensing and monetization where a SIM SPV is the owner or SIM IP is the IP advisor

02

IP Litigation Investment

Investing in IP litigation with direct involvement from SIM IP principals in all key decisions

03

IP Finance

Structured investments where the realizable value of the target’s IP is a significant factor in the investment
decision

04

IP Royalty Acquisition

Acquisition of royalties to be received by a target company based on prior licensing of IP

05

IP Tactical Opportunities

IP related transactions, including copyrights, distressed investments, refinancings, IP acquisitions, and other strategic transactions which are opportunistic in nature and require a differentiated and highly tailored solution

06

SIM Entertainment Litigation Fund

Provide funding and strategic advice to creative talent holding claims against those that have violated their rights to obtain fair and full compensation for their creative talents and efforts.

07

SIM Life Sciences

SIM Life Sciences focuses on financial and strategic opportunities in the life sciences space.

Leadership

The principals of SIM IP are regularly recognized as pioneers and global leaders in IP and finance.

Erich Spangenberg
Co-Founder, Chief Executive Officer & Senior Managing Director
David Kutcher
Co-Founder, Chief Financial Officer & Senior Managing Director
Jennifer Burdman
Managing Director
Dr. Colin Bristow
Managing Director - Head of SIM Life Sciences
Brian Berman
Director – Business Development
Media

News & Insights

View All

Our Events

10/31/24

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

10/31/24
Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Blog Posts & Firm News

Insight

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Press Release
Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Media Coverage
Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Unlocking Value in IP Investments
Leadership

The principals of SIM are regularly recognized as pioneers and global leaders in IP and investments.

Featured

News & Insights

View All
No items found.